Skip to main content
. 2015 Sep 18;59(10):6539–6550. doi: 10.1128/AAC.00813-15

TABLE 1.

Potency of GSK8853 against transient HCV replicons

Genotype Residue changea Modified protein EC50 (nM) Fold shiftb 95% confidence interval (nM)
1a Wild type NS4B 0.5 1.0 0.4–0.6
F98L NS4B 25.8 51.6 22.3–30.6
V105L NS4B 3.7 7.4 2.5–6.0
V105M NS4B 173.2 346.4 124.9–243.0
1a PBC002 Wild type NS4B 1.6 1.0 1.3–2.0
N56I NS4B >30,000 >18,750
N99H NS4B 7,364.5 4,602 5,224–10,505
1b Wild type NS4B 1.1 1.0 1.0–1.2
H94N NS4B 37.7 34.3 34.7–41.0
H94Rc NS4B 52.6 47.8 41.9–66.0
F98Lc NS4B 27.1 24.6 23.6–31.2
V105Lc NS4B 6.6 6.0 6.0–7.2
V105M NS4B 179.0 162.7 159.4–200.9
R155Q NS3 2.6 2.4 2.3–3.4
A156Tc NS3 0.9 0.8 0.60–1.5
D168A NS3 1.8 1.6 1.1–7.9
L28V NS5A 1.6 1.5 1.5–1.8
L31Vc NS5A 1.4 1.3 1.0–3.3
Y93H NS5A 1.1 1.0 0.7–1.9
C316Y NS5B 1.5 1.4 1.1–3.0
M414Tc NS5B 1.2 1.1 0.6–8.2
P495L NS5B 1.1 1.0 0.9–2.0
a

Variants are numbered according to the translated peptide sequence of the gene in which the mutation is located.

b

Fold shift is calculated for mutant replicons relative to the unaltered (wild-type) clone of the matching background.

c

Data were originally reported in reference 7.